GlobeNewswire by notified

Philips program developing AI-powered ultrasound to expand access to maternal health receives major funding boost


November 7, 2023

  • Total investment from the Bill & Melinda Gates Foundation reaches USD 60 million, accelerating expansion of new AI-guided ultrasound capabilities on Philips Lumify Handheld Ultrasound
  • Innovation helps address worldwide shortage of healthcare workers by putting diagnostic tool previously reserved for expert technicians in the hands of midwives

Amsterdam, the Netherlands –Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced it has received a second round of funding from the Bill & Melinda Gates Foundation to accelerate global adoption of AI algorithms on Philips Lumify Handheld Ultrasound. By using AI to simplify key measurements to identify abnormalities during pregnancy, training time to use the ultrasound system can be reduced from weeks to just hours, hugely expanding the pool of frontline health workers who can learn to use the technology and integrate it into routine care.

Results since the Bill & Melinda Gates Foundation provided its first phase of grant funding in 2021 have shown a positive impact in Kenya where the technology has helped drive better-informed decision-making when triaging pregnant women in rural underserved communities. The new phase of funding will support the deployment of the AI-assisted tool to underserved communities globally.

Each day, nearly 800 women around the world die from preventable causes related to pregnancy and childbirth [1], with nearly 95% of all maternal deaths occurring in low- and lower-middle-income countries in 2020. Care provided by skilled health professionals before, during and after childbirth can help save the lives of women and newborns worldwide [1].

New AI-guided algorithms assist in risk-based triaging
The World Health Organization recommends at least one ultrasound scan before 24 weeks of gestation for pregnant women to evaluate gestational age and improve detection of fetal abnormalities with greater confidence [2]. With this latest development, Philips Lumify Handheld Ultrasound will be the first point-of-care ultrasound (POCUS) device to be introduced commercially to assist non-expert users by automating image acquisition or image interpretation for a comprehensive set of obstetrics measurements, increasing quality access to early fetal ultrasound scans.

“Ultrasound is the first tool of choice to scan pregnant women, but it also requires training to understand how to scan properly and correctly in order to make the right image interpretations,” said Jeff Cohen, General Manager of Ultrasound at Philips. “By supporting front-line healthcare workers such as midwives to identify potential problems in pregnancy at an early stage, we aim to significantly reduce the number of women who die because of pregnancy. During this next phase, working with the Bill & Melinda Gates Foundation, we will bring this innovation as a commercial offering to the market to help increase quality access to care and improve maternal health in underserved and rural communities in developed and developing countries worldwide.”

“One of our key areas of focus is to build partnerships that bring together resources, expertise, and vision – working with organizations around the world to identify issues, find answers, and drive change,” said Dr. Rasa Izadnegahdar, Director, Maternal, Newborn and Child Health Discovery & Tools at the Bill & Melinda Gates Foundation. “A critical goal of our work at the Bill & Melinda Gates Foundation is to bring health technology to underserved areas of the world to help prevent women from dying in childbirth – an issue that is critical in high-income countries like the US and UK as well.”

Prototype results show increased confidence for midwives
During a trial period in Kenya, feedback on the new tool has shown positive impact. Thanks to digitalization, informatics, and AI, interpretation of the images is not required by the operator. Weeks of training for midwives have been reduced to hours, without negatively affecting confidence in triage. Expectant moms also find it comforting to know how their baby is progressing. Depending on the results, patients can be referred to a credentialed sonographer for image review and further investigation if needed.

“With this disruptive technology, we are introducing a new way of ultrasound scanning where midwives and non-expert users are guided by the algorithm to give them access to critical information they need most when triaging pregnant women in underserved areas, and rural settings,” said Matthijs Groot Wassink, General Manager for Point of Care and Obstetric Ultrasound at Philips. “The prototype identifies six critical parameters for high-risk assessments to help improve the health of both mom and baby, such as gestational age and placenta location. With the automated AI capabilities built into Philips Lumify, frontline workers can identify abnormalities earlier, helping to increase confidence and comfort of the mother in any decisions or care pathways she decides to pursue or not.”

Philips’ leadership in Ultrasound worldwide
Philips Ultrasound systems installed around the world perform an estimated 1.33 billion diagnostic and interventional procedures each year. With this latest AI-enabled POCUS prototype, Philips continues its commitment to deliver industry-first innovations in areas such as 3D imaging of the heart, AI-powered quantification tools, and ultra-mobile portable ultrasound solutions. Visit Philips Ultrasound for more information on the latest innovations in cardiology, general imaging and point-of-care OB/GYN ultrasound solutions.

More information on the program can be found in this FAQ.


For further information, please contact:

Kathy O’Reilly
Philips Global Press Office
Tel.: +1 978 221 8919

About Royal Philips

Royal Philips (NYSE: PHG, AEX: PHIA) is a leading health technology company focused on improving people's health and well-being through meaningful innovation. Philips’ patient- and people-centric innovation leverages advanced technology and deep clinical and consumer insights to deliver personal health solutions for consumers and professional health solutions for healthcare providers and their patients in the hospital and the home. Headquartered in the Netherlands, the company is a leader in diagnostic imaging, ultrasound, image-guided therapy, monitoring and enterprise informatics, as well as in personal health. Philips generated 2022 sales of EUR 17.8 billion and employs approximately 71,500 employees with sales and services in more than 100 countries. News about Philips can be found at


To view this piece of content from, please give your consent at the top of this page.
To view this piece of content from, please give your consent at the top of this page.

About GlobeNewswire by notified

GlobeNewswire by notified
GlobeNewswire by notified
One Liberty Plaza - 165 Broadway
NY 10006 New York

GlobeNewswire by notified is one of the world's largest newswire distribution networks, specializing in the delivery of corporate press releases financial disclosures and multimedia content to the media, investment community, individual investors and the general public.

Subscribe to releases from GlobeNewswire by notified

Subscribe to all the latest releases from GlobeNewswire by notified by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from GlobeNewswire by notified

Iveco Group N.V. publishes its 2024 Corporate Calendar29.11.2023 18:30:00 CET | Press release

Turin, 29th November 2023. Iveco Group N.V. (EXM: IVG) announces the following corporate calendar dates for 2024: DateEarnings releases9th FebruaryResults for 4th quarter and preliminary annual results 202310th MayResults for 1st quarter 202425th JulyResults for 2nd quarter and 1st half 20247th NovemberResults for 3rd quarter 2024 The Annual General Meeting for the approval of Iveco Group N.V.’s Financial Statements at 31st December 2023 is scheduled to take place in mid April 2024 (*). The 2024 corporate calendar is available on the corporate website: (*) In compliance with the requirements set forth by the lnstructions of the Regulation of Borsa Italiana S.p.A., please note that, should the Annual General Meeting resolve a dividend related to the 2023 financial year, the month planned for the dividend detachment (ex-date) would be April. This information is provided for the aforesaid regulatory provisions only and it cannot be interpreted in any way as a forecast


Publication on November 29, 2023 at 18:30 CET after market closing Regulated information EVS Broadcast Equipment S.A.: Euronext Brussels (EVS.BR), Bloomberg (EVS BB), Reuters (EVSB.BR) PUBLICATION OF A TRANSPARENCY NOTIFICATION (Article 14, first paragraph, of the Law of 2 May 2007 on disclosure of major holdings) On November 27, 2023, EVS Broadcast Equipment has received a transparency notification indicating that Otus Capital Management Limited now holds 4.99% of the voting rights of the company. Otus Capital Management Limited has therefore crossed down the threshold of 5%. The notification, dated November 27, 2023, contains the following information: Reason for the notification: acquisition or disposal of voting securities or voting rightsNotification by: A parent undertaking or a controlling personPersons subject to the notification requirement: Otus Capital Management Limited, 29 Queen Anne’s Gate, London SW1H 9BU, UK; Andrew GibbsTransaction date: November 24, 2023Threshold that

IDEX - Disclosure of large shareholding - 29 Nov 202329.11.2023 18:30:00 CET | Press release

Reference is made to the announcement by IDEX Biometrics ASA on 15 November 2023 regarding a private placement of shares, and the announcement by Sundt AS on 16 November 2023 regarding lending of shares. As a result of the re-delivery of shares, Sundt AS discloses the following information pursuant to Section 4-2 of the Norwegian Securities Trading Act and the Securities Trading Act Regulations: On 29 November 2023, following re-delivery of 45,000,000 shares in IDEX, Sundt AS’s holdings of shares increased from 61,512,922 shares to 106,512,922 which represents 7.6% of the share capital based on 1,396,621,040 shares in issue following the private placement. This notice was published by Erling Svela, Vice president of finance, on 29 November 2023 at 18:30 CET on behalf of IDEX Biometrics ASA.

SMISS launched its electronic vapor gadgets technology platform TempSure™, the world's 1st cannabis vape hardware featuring intelligent duplex communication29.11.2023 18:00:00 CET | Press release

SHENZHEN, China, Nov. 29, 2023 (GLOBE NEWSWIRE) -- As one of the largest exhibitions in the global cannabis industry, the MJBizCon 2023 CBD/THC/Cannabis Expo opened in Las Vegas as scheduled. On November 29th local time, SMISS officially launched the World's 1st Cannabis Vape Hardware Featuring Intelligent Duplex Communication, TempSure™ at the event. The platform utilizes advanced technology to provide users with the best intelligent vaporization experience. The name TempSure™ implies precise vaporization temperature control, offering users the perfect CBD vaporization experience. TempSure™ has developed an intelligent MCU control chip and a proprietary PID dynamic compensation technology solution. By accurately monitoring the heating state of CeramicMesh™ coil vaporization (oil conductivity, oil temperature, and smoke signal), it dynamically adjusts the optimal power energy output to achieve accurate heating temperature control for scientific vaporization. This enables users to exper

Intervest Offices & Warehouses NV: Press release – Persbericht – Communiqué de presse: publication of a transparency notification29.11.2023 18:00:00 CET | Press release

Dear Madam, Sir, Please find hereunder the links to Intervest Offices & Warehouses’ latest press release regarding the publication of a transparency notification. Geachte mevrouw, meneer, Gelieve hierbij de links te vinden naar het recente persbericht van Intervest Offices & Warehouses betreffende de openbaarmaking over transparantiekennisgeving. Chère Madame, Cher Monsieur, Veuillez trouver ci-dessous les liens vers le récent communiqué de presse d’Intervest Offices & Warehouses concernant la communication relative à une notification de transparence. Attachments ENG_transparency notification_20231128_FINNL_transparency notification_20231128_FINFR_transparency notification_20231128_FIN